Eli Lilly's stock price has experienced movement, with some reports indicating a dip despite market gains, while others note a decline of a specific percentage. The company has been involved in a deal to acquire AtaiBeckley, which has had an impact on psychedelic stocks. Eli Lilly's stock and the deal's effects on other stocks, such as Atai and possibly CMPS, are being analyzed and reported on by various financial outlets.